| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |